XBiotech Net Debt To E B I T D A from 2010 to 2024
| XBIT Stock | USD 7.61 0.26 3.54% |
Net Debt To EBITDA | First Reported 2010-12-31 | Previous Quarter 5.59254599 | Current Value 4.62 | Quarterly Volatility 6.89531227 |
Check XBiotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among XBiotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.9 M, Interest Expense of 985.4 K or Selling General Administrative of 7.9 M, as well as many indicators such as Price To Sales Ratio of 14.88, Dividend Yield of 0.18 or PTB Ratio of 0.53. XBiotech financial statements analysis is a perfect complement when working with XBiotech Valuation or Volatility modules.
XBiotech | Net Debt To E B I T D A |
Latest XBiotech's Net Debt To E B I T D A Growth Pattern
Below is the plot of the Net Debt To E B I T D A of XBiotech over the last few years. It is a leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company's net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). XBiotech's Net Debt To EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in XBiotech's overall financial position and show how it may be relating to other accounts over time.
| Net Debt To E B I T D A | 10 Years Trend |
|
Net Debt To E B I T D A |
| Timeline |
XBiotech Net Debt To E B I T D A Regression Statistics
| Arithmetic Mean | 4.97 | |
| Geometric Mean | 2.01 | |
| Coefficient Of Variation | 138.64 | |
| Mean Deviation | 4.78 | |
| Median | 2.47 | |
| Standard Deviation | 6.90 | |
| Sample Variance | 47.55 | |
| Range | 24.4573 | |
| R-Value | 0.48 | |
| Mean Square Error | 39.62 | |
| R-Squared | 0.23 | |
| Significance | 0.07 | |
| Slope | 0.73 | |
| Total Sum of Squares | 665.63 |
XBiotech Net Debt To E B I T D A History
About XBiotech Financial Statements
XBiotech shareholders use historical fundamental indicators, such as Net Debt To E B I T D A, to determine how well the company is positioned to perform in the future. Although XBiotech investors may analyze each financial statement separately, they are all interrelated. The changes in XBiotech's assets and liabilities, for example, are also reflected in the revenues and expenses on on XBiotech's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Debt To EBITDA | 5.59 | 4.62 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for XBiotech Stock Analysis
When running XBiotech's price analysis, check to measure XBiotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XBiotech is operating at the current time. Most of XBiotech's value examination focuses on studying past and present price action to predict the probability of XBiotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XBiotech's price. Additionally, you may evaluate how the addition of XBiotech to your portfolios can decrease your overall portfolio volatility.